A clinical trial involving gonadorelin was updated on August 28, 2026. The trial, registered as NCT02858336 and titled the CaREFREE Study (Calorie Restriction, Environment and Fitness: Reproductive Effects Evaluation Study), is now listed with a status of Completed.
The trial is registered with a phase designation of NA on ClinicalTrials.gov. No results, outcomes, or efficacy data are included in this status update. The update reflects only a change in the trial's listed status as of the date given.
Gonadorelin is an approved compound. This event pertains solely to the administrative status of the CaREFREE Study as recorded in the public trial registry. No additional details about study design, participant outcomes, or findings are provided in this update.
Readers seeking further information can consult the trial record directly at ClinicalTrials.gov under the identifier NCT02858336. For general background on gonadorelin, see the compound overview linked with this brief.